QuantAbundanciaAbundance, Quantified.

News

High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.

21,128 signal articles · 533 in last 24h · 103,894 total before filter · latest 7m ago
533last 24h
2508last 7d
477● bullish (7d)
255● bearish (7d)
197publishers
AllMacro225Earnings1487M&A143Regulatory15Product5Analyst29
✕ clear all filtersSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Bank of America revamps AMD stock price target for 2026
TheStreet11d agoneutral
Bank of America revamps AMD stock price target for 2026

For years, the AI chip conversation has had one dominant name and a long list of challengers trying to close the gap. Most of them haven't. One of them is starting to look different, and Bank of America just made that case in writing. Bank of America analyst Vivek Arya, who covers semiconductors ...

How Verizon’s Q2 Results, Dark-Fiber Deal With Google And Raised Outlook At Verizon (VZ) Has Changed Its Investment Story
Simply Wall St.11d agoneutral
How Verizon’s Q2 Results, Dark-Fiber Deal With Google And Raised Outlook At Verizon (VZ) Has Changed Its Investment Story

Verizon Communications has reported its second-quarter 2026 results, with revenue of US$34,253 million and net income of US$3,835 million, while also completing US$3,500 million of share repurchases under its January 2026 buyback program. Alongside the earnings release, Verizon unveiled a dark-fiber deal with Google worth more than US$1 billion and raised its 2026 outlook for adjusted earnings, free cash flow and share repurchases, pointing to growing emphasis on AI infrastructure...

AMD price target boosted on strengthening AI outlook
Proactive12d agoneutral
AMD price target boosted on strengthening AI outlook

Advanced Micro Devices Inc (NASDAQ:AMD, XETRA:AMD) saw its price target raised to $600 from $450 by Wedbush following the chipmaker’s Advancing AI 2026 event, with the analysts writing that new partnerships and improving supply chain conditions increased confidence in the company’s data center...

Investing.com12d agobearish
JPMorgan cuts Rollins to Neutral on demand uncertainty, slashes price target

Investing.com -- JPMorgan downgraded Rollins to Neutral from Overweight and cut its price target to $45 from $70, saying uncertainty around weakening residential demand and a slower-than-expected margin recovery has made the pest control company's near-term risk-reward less compelling despite its intact long-term growth story.

WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook
StockStory12d agobullish
WST Q2 Deep Dive: Biologics and High-Value Components Drive Upgraded Outlook

Healthcare products company West Pharmaceutical Services (NYSE:WST) reported Q2 CY2026 results exceeding the market’s revenue expectations, with sales up 13.8% year on year to $872.3 million. Guidance for next quarter’s revenue was better than expected at $827.5 million at the midpoint, 0.8% above analysts’ estimates. Its non-GAAP profit of $2.37 per share was 13.9% above analysts’ consensus estimates.